T4	condition 112 118	Seroma
T5	total-participants 600 602	96
T6	eligibility 572 594	breast cancer patients
T7	eligibility 604 681	undergoing latissimus dorsi flap reconstruction performed by a single surgeon
T8	intervention-participants 750 752	23
T9	intervention-participants 788 790	26
T10	control 800 823	normal saline (control)
T11	control-participants 829 831	27
T12	intervention-participants 919 921	20
T13	outcome-Measure 942 948	seroma
T14	outcome-Measure 950 962	drain output
T15	outcome-Measure 968 993	days to last drain remova
T16	outcome 1145 1164	overall seroma rate
T17	outcome 1234 1254	drainage for weeks 1
T19	iv-bin-percent 1361 1372	5.0 percent
T20	iv-bin-abs 1378 1379	1
T21	cv-bin-percent 1429 1441	34.5 percent
T22	iv-bin-percent 1451 1463	27.6 percent
T23	iv-bin-percent 1484 1496	37.6 percent
T24	outcome 1656 1692	incidence of all other complications
T2	outcome 1337 1357	incidence of seromas
T3	cv-cont-mean 1559 1568	35.5 days
T18	iv-cont-mean 1578 1587	39.5 days
T25	iv-cont-mean 1604 1613	37.4 days
T26	iv-cont-mean 1629 1638	25.8 days
T27	outcome 1499 1518	Drains were removed
T1	intervention 50 108	Fibrin Glue, Triamcinolone Acetonide, and Quilting Sutures
